Nicotinamide N-methyltransferase (NNMT): A key enzyme in cancer metabolism and therapeutic target
Authors:
- 23 September 2024
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 142 (Pt B) , 113208
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Does the liver facilitate aging‐related cognitive impairment: Conversation between liver and brain during exercise?Journal of Cellular Physiology, 2024
- NNMT‐DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation InhibitionAdvanced Science, 2022
- Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic miceJournal of Cachexia, Sarcopenia and Muscle, 2021
- Nicotinamide N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effectMolecular Carcinogenesis, 2020
- High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancerCancer Medicine, 2020
- Elevated N‐methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoformMolecular Oncology, 2019
- Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2017
- Fatty Liver and Fibrosis in Glycine N -Methyltransferase Knockout Mice Is Prevented by NicotinamideHepatology, 2010
- Gene expression analysis of renal carcinoma: adipose differentiation‐related protein as a potential diagnostic and prognostic biomarker for clear‐cell renal carcinomaThe Journal of Pathology, 2005
- Hemostatic alterations in cancer patientsCancer and Metastasis Reviews, 1992